Pierre Giglio

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Egfrviii-expressing Glioblastoma, Neuro-oncology, Act Iv +10

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma

Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal et al. · New England Journal of Medicine · 2023 · 606 citations · Full text

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Linda M. Liau, Keyoumars Ashkan, Steven Brem et al. · JAMA Oncology · 2022 · 356 citations · Full text

Cerebral Blood Volume Measurements by Perfusion-Weighted MR Imaging in Gliomas: Ready for Prime Time in Predicting Short-Term Outcome and Recurrent Disease?

Sotirios Bisdas, M B Kirkpatrick, Pierre Giglio et al. · American Journal of Neuroradiology · 2009 · 111 citations · Full text

Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy.

Philip Lee, Ben Murphy, Rickey Miller et al. · PubMed · 2015 · 84 citations

Histone Modifications, Hdac Inhibitors, Epigenetic Change +24